BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. Financials - Benzinga

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc.

BCLIOTCQB

Trade with Public

Trade with Public

$1.17

At close: Aug 5, 5:00 PM EST

$0.8185

-0.35-30.05%

After Hours: Jun 5, 8:09 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. Financials

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Brainstorm Cell Q2 EPS $(0.35) Down From $(0.34) YoY

Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.

Benzinga Newsdesk

PRO
Brainstorm Cell Q1 EPS $(0.19) Beats $(0.36) Estimate

Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.36) by 47.22 percent. This is a 57.78 percent increase over losses of $(0.45) per share from the

Benzinga Newsdesk

PRO
Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate

Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 60.78 percent increase over losses of $(0.51) per share from the

Benzinga Newsdesk

PRO
Brainstorm Cell Q3 EPS $(0.19) Beats $(0.37) Estimate

Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.37) by 48.65 percent. This is a 62.75 percent increase over losses of $(0.51) per share from the

Benzinga Newsdesk

PRO
Brainstorm Cell Q2 EPS $(0.34) Beats $(0.37) Estimate

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 43.33 percent increase over losses of $(0.60) per share from

Benzinga Newsdesk

A Peek at Brainstorm Cell's Future Earnings

Benzinga Insights